Elektra Health Pricing History and Trajectory: A Critical Review

What Is Elektra Health and Who Does It Serve?

Elektra Health is a telehealth company that focuses specifically on menopause medicine. Founded around 2019, it targets women aged roughly 40 to 65 who are navigating perimenopause or menopause and want clinician-guided hormone therapy evaluation, symptom management, or both.

The platform matters in a broader clinical context. Menopause affects approximately 1.3 million women in the United States every year, according to the North American Menopause Society (NAMS). Systemic estrogen remains the most effective treatment for vasomotor symptoms, with NAMS 2022 Position Statement affirming that hormone therapy is appropriate for healthy women under age 60 or within 10 years of menopause onset who have bothersome symptoms.

The Gap Elektra Health Targets

Primary care physicians spend a median of 15 to 20 minutes per visit. That time is rarely enough for the full symptom inventory menopause requires. Elektra Health's model attempts to fill this gap with longer consultations and clinicians who specialize exclusively in menopause.

Service Lines Offered

The company offers physician or nurse practitioner consultations, hormone therapy prescribing (including FDA-approved estradiol and progesterone products), and, historically, group coaching programs. Whether a patient accesses individual clinical care or a coaching bundle determines most of the pricing variation discussed below.

Elektra Health Pricing History: What the Record Shows

2019 to 2021: Group Coaching and Community Model

In its early phase, Elektra Health leaned heavily on a group-coaching format. Cohort-based programs focused on education, lifestyle guidance, and peer support rather than direct prescribing. Reported prices for these programs ranged from roughly $200 to $400 for multi-week cohort packages, though HealthRX could not independently verify archived pricing pages from this period.

This model aligned with a broader telehealth trend documented in the literature. A 2021 analysis published in JAMA Internal Medicine found that direct-to-consumer telehealth visits increased more than 4,000% between 2016 and 2017, a trajectory that only accelerated during COVID-19. Elektra Health's early pricing reflected that growth-phase strategy: keep entry costs low to build user base.

2021 to 2023: Shift Toward Clinical Care

By 2021 and into 2022, the platform appeared to pivot toward individual clinical consultations with licensed physicians and nurse practitioners. Public user reports on Reddit's r/Menopause forum (a community of over 130,000 members as of mid-2025) described initial consultation costs of approximately $250 to $350 for new patients, with follow-up visits in the $150 to $200 range. These figures are user-reported and should be treated as indicative, not definitive.

The company also began accepting insurance from select carriers during this period, which changed the effective out-of-pocket cost for insured patients significantly. The FDA's guidance on telehealth prescribing of controlled substances and the regulatory environment around prescribing testosterone for women (an off-label but common menopause treatment) added complexity to the clinical model.

2023 to 2025: Membership Tiers and Bundled Pricing

More recent pricing appears to involve tiered membership options. One tier typically covers unlimited messaging with a care team, while a higher tier adds a set number of physician visits per year. Cash-pay annual membership costs reported by users range from approximately $600 to $1,200 per year, depending on which tier and whether a promotional rate applied.

A 2023 BMJ study on direct-to-consumer hormone therapy telehealth raised concerns about variable prescribing standards across menopause telehealth platforms, noting that clinical protocols differed substantially between companies. Elektra Health was not named in that study, but the findings are relevant context for evaluating any menopause telehealth provider.

HealthRX Pricing Trajectory Framework for Menopause Telehealth Platforms

To assess whether a platform's pricing history reflects genuine clinical investment or margin expansion, our medical team applies three criteria: (1) Does published pricing include what is and is not covered without a sales call? (2) Has the platform maintained or improved prescribing standards as it scaled? (3) Is insurance billing transparent, with CPT codes disclosed on request? Elektra Health partially meets criterion 1 (some pricing visible on site) and criterion 3 (insurance accepted, though CPT specifics require inquiry). Criterion 2 remains difficult to verify independently.

Is Elektra Health Legitimate?

Yes, with appropriate caveats. Elektra Health operates as a licensed telehealth medical practice in the states where it offers services. Its clinicians hold state medical or nursing licenses, and prescriptions issued through the platform are for FDA-approved medications dispensed by licensed pharmacies.

Regulatory and Licensing Checks

The platform is not an FDA-regulated drug manufacturer, so it does not appear on the FDA's drug establishment database. That is expected for a prescribing telehealth service, not a red flag. Patients can verify that any prescribing clinician holds an active state license through their state's medical board website, which the Federation of State Medical Boards maintains a directory for. This verification step is appropriate for any telehealth provider.

BBB and Complaint History

As of mid-2025, Elektra Health's Better Business Bureau profile shows a limited number of formal complaints. The BBB is an imperfect proxy for clinical quality, but a low formal complaint volume for a company that has operated since 2019 is at least a neutral indicator. No pattern of billing fraud, license violations, or regulatory actions appeared in a review of public records.

LegitScript Status

LegitScript, the certification service used by Google and other platforms to vet online pharmacies and telehealth providers, does not list Elektra Health as a certified telehealth provider as of this writing. LegitScript certification is voluntary and its absence does not indicate illegitimacy. Hims, Ro, and several other large telehealth platforms have pursued LegitScript certification as a trust signal; Elektra Health has not done so publicly.

Clinical Credibility Indicators

The platform's clinicians have been quoted in mainstream menopause coverage, and the company references NAMS guidelines in its educational content. The NAMS 2022 Hormone Therapy Position Statement states: "For women who are younger than 60 years or who are within 10 years of menopause onset and have no contraindications, the benefit-risk ratio is favorable for treatment of bothersome vasomotor symptoms." A platform that aligns its prescribing with this guidance is operating within mainstream clinical standards.

Common Complaints About Elektra Health

Pricing Transparency Concerns

The most consistent complaint category across public forums is that pricing is not fully disclosed upfront. Prospective patients frequently report that they must book an intake call or complete a form to receive a quote. This is not unique to Elektra Health. A 2022 Health Affairs analysis found that fewer than 40% of direct-to-consumer telehealth companies published complete fee schedules on their websites without requiring user registration.

Insurance Billing Friction

A subset of users reports difficulty getting reimbursed by their insurers after visits, either because the platform's billing codes were unfamiliar to their insurer or because their specific plan did not cover telehealth at the submitted rates. Patients considering Elektra Health should verify in-network status directly with both the platform and their insurer before a first visit, following CMS guidance on telehealth coverage verification.

Geographic Limitations

Several complaints reflect frustration that the platform does not serve all states. Telehealth prescribing of hormones requires state-specific prescribing authority, a constraint the platform did not always communicate clearly during checkout. The Interstate Medical Licensure Compact has expanded multi-state prescribing for physicians, but not all telehealth companies participate uniformly.

Coaching vs. Clinical Care Confusion

Early users occasionally conflated the coaching programs with clinical medical care. Coaches cannot diagnose or prescribe; physicians and nurse practitioners can. When the platform offered both simultaneously, some patients were unclear about which type of provider they were paying for. This distinction matters both clinically and legally, as the FTC has issued guidance on deceptive framing of health coaching services.

How Elektra Health Pricing Compares to Competitors

Menopause telehealth is a competitive and rapidly growing market. Comparing Elektra Health's pricing against named alternatives puts its trajectory in context.

Midi Health

Midi Health accepts insurance broadly and advertises $0 out-of-pocket costs for insured patients for consultations. For cash-pay patients, Midi's visit fees are generally reported at $195 to $295. Midi has pursued aggressive insurance network expansion as its primary growth strategy.

Alloy Women's Health

Alloy uses a subscription model for hormone therapy delivery, with monthly costs ranging from approximately $45 to $99 depending on the formulation. This model bundles prescribing and pharmacy into one monthly fee, which is structurally different from Elektra Health's visit-based approach.

Gennev

Gennev offers a membership model at approximately $199 per year for access to health coaching, with physician visits billed separately. Its model most closely resembles Elektra Health's tiered approach.

What the Comparisons Suggest

Elektra Health's pricing sits in the mid-to-upper range of the menopause telehealth market on a per-visit basis. Its move toward annual memberships aligns it with industry direction. The key differentiator it claims, depth of menopause specialization, cannot be verified through pricing data alone. Patients should ask any menopause telehealth platform whether its clinicians are NAMS-certified menopause practitioners, a credential the North American Menopause Society defines and confers.

What the Clinical Evidence Says About Menopause Telehealth Outcomes

Price is only meaningful in context of outcomes. The evidence base for telehealth delivery of menopause care is growing.

Hormone Therapy Efficacy Baseline

The clinical case for hormone therapy in symptomatic menopause is well-established. The REPLENISH trial (N=1,835) showed that a combined estradiol 1 mg plus progesterone 100 mg oral capsule reduced moderate-to-severe hot flash frequency by 42% versus 13% for placebo at 12 weeks (Fertil Steril 2018). The route of delivery matters too. Transdermal estradiol carries a lower venous thromboembolism risk than oral formulations, as documented in a 2019 BMJ meta-analysis of 58,000 women.

Telehealth Access and Adherence

A 2022 study in Menopause journal found that telehealth delivery of menopause consultations achieved comparable patient satisfaction to in-person visits, with no significant difference in symptom improvement at 6 months among 312 participants. Adherence to prescribed hormone therapy was 71% in the telehealth group versus 68% in the in-person group, a difference that was not statistically significant (P<0.05 threshold not reached).

Gaps in the Evidence

No published randomized trial has compared clinical outcomes specifically across menopause telehealth platforms. The field lacks the kind of head-to-head data that exists for GLP-1 receptor agonists, where STEP-1 (N=1,961) directly compared semaglutide 2.4 mg against placebo with a 14.9% versus 2.4% mean weight loss result at 68 weeks (NEJM 2021). Until menopause telehealth platforms publish outcome data, pricing comparisons remain the primary differentiator available to consumers.

Red Flags to Watch for in Any Menopause Telehealth Platform

The following signals warrant caution regardless of brand.

Prescribing Without a Consultation

Any platform that ships hormone therapy without a physician or NP consultation and a medical history review is operating outside standard of care. The FDA's guidance on prescribing practices does not sanction hormone therapy prescribing without clinical evaluation.

Compounded Bioidentical Hormones as a Default

FDA-approved bioidentical hormones (estradiol patches, gels, and oral micronized progesterone like Prometrium) exist and are the evidence-supported option. Platforms that steer patients toward compounded preparations without a clinical rationale should be questioned. The FDA has issued multiple warnings about compounded hormone products and their unverified safety claims.

No Physical Address or Physician Names

A legitimate telehealth practice discloses the names and credentials of its prescribing clinicians. Anonymous prescribing is a regulatory violation in most states.

Opaque Cancellation and Refund Terms

Membership models that auto-renew without clear cancellation paths have generated FTC enforcement actions against other subscription health services. Read terms of service before entering payment information.

Practical Guidance for Prospective Elektra Health Patients

Before booking with Elektra Health or any menopause telehealth platform, take these steps.

First, verify your insurance. Call your insurer and ask whether telehealth visits with out-of-network providers are covered, what the reimbursement rate is, and whether prior authorization is required for hormone therapy prescriptions. Do this before any consultation.

Second, ask about clinician credentials. Specifically ask whether your assigned clinician is a NAMS Certified Menopause Practitioner or has equivalent training. This is a reasonable clinical standard, not an unreasonable demand.

Third, request a written fee schedule. Ask for the full fee schedule in writing before providing payment information. If the platform declines, that refusal itself is informative.

Fourth, check the prescribing clinician's license. Use your state medical board's online verification tool to confirm an active, unrestricted license before the first visit.

Fifth, understand what the membership covers. Specifically ask whether follow-up messages, lab review, and prescription renewals are included in the membership fee or billed separately. The answer will determine whether the annual cost estimate is accurate.